Last $73.14 USD
Change Today -2.40 / -3.18%
Volume 7.1M
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wenqing Yao Ph.D.

Executive Vice President of Discovery Medicinal and Process Chemistry, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Dr. Wenqing Yao,,Ph.D. serves as Executive Vice President of Discovery Medicinal and Process Chemistry at Incyte Corporation and served as its Senior Vice President of Discovery Chemistry. Dr. Yao joined Incyte in February 2002 as Director of Chemistry. Dr. Yao has over 20 years of experience in medicinal chemistry. For the past nine years, Dr. Yao has held roles of increasing responsibility at Incyte, most recently as Vice President of Chemistry. Dr. Yao held scientific ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
The University of Pennsylvania
MS
Nankai University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $73.14 USD -2.40

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.